---
figid: PMC9085237__aging-14-204038-g014
pmcid: PMC9085237
image_filename: aging-14-204038-g014.jpg
figure_link: /pmc/articles/PMC9085237/figure/f14/
number: Figure 14
figure_title: ''
caption: Effects of presence of WT-TP53 on respiratory capacity. The data for MIA-PaCa-2
  + pLXSN is the same control as presented in []. Both MIA-PaCa-2 + pLXSN and MIA-PaCa-2
  + WT-TP53 were examined the same time on the Seahorse machine. The measurements
  were made 5 times (5 replicates). The data presented in  are the means and standard
  error of the means (SEM).
article_title: Wild type and gain of function mutant TP53 can regulate the sensitivity
  of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3
  pathway inhibitors, nutraceuticals and alter metabolic properties.
citation: James A. McCubrey, et al. Aging (Albany NY). 2022 Apr 30;14(8):3365-3386.
year: '2022'

doi: 10.18632/aging.204038
journal_title: Aging (Albany NY)
journal_nlm_ta: Aging (Albany NY)
publisher_name: Impact Journals

keywords:
- TP53
- targeted therapy
- PDAC
- chemotherapeutic drugs
- metabolic properties

---
